. 2020 Feb 26;16(1):10–19. doi: 10.12965/jer.1938748.374

Table 1.

Study characteristics

Study	Group	No. of participants Intervention	Sex (male/female)	Age (yr), mean±SD	Cerebral palsy type GMFCS	Dosage	Outcome
Dodd and Foley (2007)	Experimental	7 PBWSTT+usual physical activity program	5/2	8.5±2.6	Athetoid quadriplegia 4 Spastic diplegia 1 Spastic quadriplegia 2 GMFCS level 3(2), 4(5)	30 min 2 day×6 wk	10 MWT 10-MWT
Dodd and Foley (2007)	Control	7 Usual physical activity program	5/2	9.5±2.9	Athetoid quadriplegia 4 Spastic diplegia 1 Spastic quadriplegia 2 GMFCS level 3(2), 4(5)	30 min 2 day×6 wk	10 MWT 10-MWT

Cherng et al. (2007)	Experimental	4 TBWS+regular therapeutic treatment	2/2	4.5±2	Spastic diplegia 4 GMFCS level 2(1), 3(3)	20 min 2 or 3 day×12 wk	Gait speed Cadence Gait stride length Gait double limb support
Cherng et al. (2007)	Control	4 Regular therapeutic treatment	4/0	4.5±2	Spastic diplegia 4 GMFCS level 2(1), 3(3)	20 min 2 or 3 day×12 wk

Willoughby et al. (2010)	Experimental	12 PBWSTT+usual physiotherapy	6/6	10.3±3.1	Not report GMFCS level 3(5), 4(7)	30 min 2 day×9 wk	10 MWT 10-MWT SFA
Willoughby et al. (2010)	Control	14 Over ground walking+usual physiotherapy	9/5	11.2±4.1	Not report GMFCS level 3(3), 4(11)	30 min 2 day×9 wk	10 MWT 10-MWT SFA

Gharib et al. (2011)	Experimental	15 TGT+traditional physical therapy	10/5	11.9±1.1	Spastic hemiplegia 15 GMFCS level 2(15)	15 min 3 day×12 wk	Gait speed Step length Ambulation index Time of support
Gharib et al. (2011)	Control	15 Traditional physical therapy	6/9	11.2±1.1	Spastic hemiplegia 15 GMFCS level 2(15)	15 min 3 day×12 wk	Gait speed Step length Ambulation index Time of support

Johnston et al. (2011)	Experimental	14 SSTTEP	7/7	9.7±2.2	Spastic diplegia 8 Spastic quadriplegia 6 GMFCS level 2(1), 3(9), 4(4)	30 min 5 day×12 wk	Spasticity Strength Motor control GMFM Cadence Step length PODCI
Johnston et al. (2011)	Control	12 Strengthening	7/5	9.6±2.4	Spastic diplegia 4 Spastic quadriplegia 6 Spastic triplegia 2 GMFCS level 2(1), 3(6), 5(5)	30 min 5 day×12 wk

Chrysagis et al. (2012)	Experimental	11 TGT	6/5	15.9±2	Spastic diplegia 9 Spastic tetraplegia 2 GMFCS level 1(3), 2(4), 3(4)	30 min 3 day×12 wk	GMFM 10-MWT MAS
Chrysagis et al. (2012)	Control	11 Conventional physiotherapy	7/4	16±1.6	Spastic diplegia 10 Spastic tetraplegia 1 GMFCS level 1(2), 2(5), 3(4)		GMFM 10-MWT MAS

Grecco et al. (2013)	Experimental	16 TGT	6/10	6.8±2.6	Not report GMFCS level 1(5), 2(8), 3(3)	30 min 2 day×7 wk	6 MWT TUG BBS
Grecco et al. (2013)	Control	17 Over ground walking	9/8	6.0±1.5	Not report GMFCS level 1(8), 2(7), 3(2)	30 min 2 day×7 wk	6 MWT TUG BBS

Hösl et al. (2018)	Experimental	10 BDTT	Not report	12±4	Spastic diplegia 8 Spastic hemiplegia 2 GMFCS level 1(4), 2(6)	23 min 3 day×9 wk	Gait speed Cadence Step length GMFM TUG MAS Ankle joint Muscle-tendon Total strain Stiffness
Hösl et al. (2018)	Control	10 Stretching	Not report	12±4	Spastic diplegia 8 Spastic hemiplegia 2 GMFCS level 1(4), 2(6)	23 min 3 day×9 wk

SD, standard deviation; GMFCS, gross motor function classification scale; PBWSTT, partial body weight supported treadmill training; 10MWT, 10-min walking test; 10-MWT, 10-m walking test; TBWS, treadmill training with body weight support; SSTTEP, supported speed treadmill training exercise program; GMFM, gross motor function measure; PODCI, pediatric outcomes data collection instrument; TGT, treadmill gait training; 6 MWT, 6-min walking test; BBS, Berg balance scale; PBWSTT, partial body weight supported treadmill training; SFA, school function assessment travel scale; TUG, Timed Up and Go test; MAS, modified Ashworth scale; BDTT, backward downhill treadmill training.